Classification, etiology, diagnosis and treatment of prostatitis. Other types of prostatitis. Acute and chronic prostatitis;Clasificación, etiología, diagnóstico y tratamiento de las prostatitis. Otros tipos de prostatitis

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 23, Issue SUPPL.4, 2005, Pages 47-56

  Jiménez Cruz, Juan Fernando ^a   Broseta Rico, Enrique ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Acute prostatitis; Chronic pelvic pain syndrome; Chronic prostatitis; Prostatitis

Indexed keywords

ALFUZOSIN; ANTIBIOTIC AGENT; AZTREONAM; CEFTRIAXONE; DOXYCYCLINE; FINASTERIDE; FOSFOMYCIN; INDOMETACIN; LEVOFLOXACIN; MINOCYCLINE; OFLOXACIN; PENTOSAN POLYSULFATE; PHENOXYBENZAMINE; PIPEMIDIC ACID; QUERCETIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAMSULOSIN; TERAZOSIN; TRIMETHOPRIM; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIINFECTIVE AGENT;

ANTIMICROBIAL THERAPY; CHRONIC PROSTATITIS; CYTOLOGY; DISEASE CLASSIFICATION; DRUG DIFFUSION; ECHOGRAPHY; HUMAN; IMMUNE RESPONSE; PATHOGENESIS; PHYSICAL EXAMINATION; PREVALENCE; PROSTATE BIOPSY; PROSTATITIS; REVIEW; SEMEN ANALYSIS; SYMPTOMATOLOGY; URINALYSIS; ACUTE DISEASE; ALGORITHM; BACTERIAL INFECTION; CASE MANAGEMENT; CHRONIC DISEASE; CLASSIFICATION; HEALTH CARE ORGANIZATION; LEUKOCYTE COUNT; MALE; MICROBIOLOGY; PALPATION; PELVIS PAIN SYNDROME; SPERM; UNITED STATES; URODYNAMICS;

ACUTE DISEASE; ADRENERGIC ALPHA-ANTAGONISTS; ALGORITHMS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CASE MANAGEMENT; CHRONIC DISEASE; HUMANS; LEUKOCYTE COUNT; MALE; NATIONAL INSTITUTES OF HEALTH (U.S.); PALPATION; PELVIC PAIN; PREVALENCE; PROSTATITIS; SEMEN; UNITED STATES; URODYNAMICS;

EID: 33749071402     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13091448     Document Type: Article

References (75)

1. Krieger JN, Ross SO, Deutsch L, Riley DE. Seminal fluid analysis in chronic prostatitis/chronic pelvic pain syndrome. Andrologia. 2003;35:266-70.
2. Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health Chronic Prostatitis Symptom Index. J Urol. 2001;165:842-5.
3. Krieger JN, Riley DE, Cheah PY, Liong ML, Yuen KH. Epidemiology of prostatitis: new evidence for a world-wide problem. World J Urol. 2003;2:70-4.
4. García-Ortells D, Navío S, Sanz E, Gómez I, García R. Epidemiología y demografía de la prostatitis. Urol Integr Invest. 200;9:99-104.
5. Roberts RO, Jacobson DJ, Girman CJ, Rhodes T, Lieber MM, Jacobsen SJ. Prevalence of prostatitis-like symptoms in a community based cohort of older men. J Urol. 2002;168:2467-71.
6. McNaughton-Collins M, Meigs JB, Barry MJ, Walker E, Giovannucci E, Kawachi I. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol. 2002;167:1363-6.
7. Litwin MS, McNaughton-Collins M, Fowler FJ, Nickel JC, Calhoun EA, Pontari MA, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999;162:369-75.
8. Mehik A, Hellstrom P, Lukarinen O, Sarpola A, Jarvelin M. Epidemiology of prostatitis in Finnish men: a population based cross-sectional study. BJU Int. 2000;86:443-8.
9. Drach GW, Meares EM, Fair WR, Stamey TA. Classification of benign disease associated with prostatic pain prostatitis or prostatodynia. J Urol. 1978;120:266-76.
10. Krieger JN, Nyberg L, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282:236-7.
11. Carver BS, Bozeman CB, Williams BJ, Venable DB. The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen. J Urol. 2003;169:589-91.
12. Hochreiter W, Z'Brun S, Hochreiter WW. Síndrome del dolor pélvico crónico y disfunción del vaciado. Curr Urol Reports. 2005;4:15-20.
13. Hruz P, Danuser H, Studer UE. Non-inflammatory chronic pelvic pain syndrome can be caused by bladder neck hypertrophy. Eur Urol. 2003;44:106-10.
14. Kirby RS, Lowe D, Bultitude MI Shuttleworth KE. Intraprostatic urinary reflux: an etiological factor in abacterial prostatitis. Br J Urol. 1982;121:729-31.
15. Persson BE, Ronquist G. Evidence for a mechanistic association between non-bacterial prostatitis and levels of urate and creatinine in expressed prostatic secretion. J Urol. 1996;155:958-60.
16. McNeal JE. Regional morphology and pathology of the prostate. Amer J Clin Path. 1968;49:347-57.
17. Nickel JC, Costerton JW. Bacterial localization in antibiotic refractory chronic bacterial prostatitis. Prostate. 1993;23:107-14.
18. Ludwig M, Steltz C, Huwe P, Schaffer R, Altmannsberger M, Weidner W. Immunocytological analysis of leukocyte subpopulations in urine specimens before and after prostatic massage. Eur Urol. 2001;39:277-82.
19. Nadler RB, Koch AE, Calhoun EA, Campbell PL, Pruden DL, Bennett CL, et al. IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol. 2000;164:214-8.
20. Krieger JN, Egan KJ, Ross SO, Jacobs R, Berger R. Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis". Urology. 1996;48:715-72.
21. Miller JL, Rothman I, Bavendam TG, Berger RE. Prostatodynia and interstitial cystitis: one and the same? Urology. 1995;45:587-90.
22. Clemens JQ, Nadler RB, Schaeffer AJ, Belani J, Albaugh J, Bushman W. Biofeedback, pelvic floor reeducation and bladder training for male chronic pelvic pain syndrome. Urology. 2000;56:951-5.
23. Hetrick DC, Ciol MA, Rothman I, Turner JA, Forest M, Berger RI. Musculoeskeletal dysfunction in men with chronic pelvic pain syndrome type III: a case control study. J Urol. 2003;170:828-31.
24. Yang CC, Lee JC, Kromm BG, Ciol MA, Berger RE. Pain sensitization in male chronic pelvic pain syndrome: why are symptoms so difficult to treat? J Urol. 2003;170:823-6.
25. Pavone C, Caldarera E, Liberti P, Miceli V, Di Trapani D, Serretta V, et al. Correlation between chronic prostatitis syndrome and pelvic venous disease: a survey of 2,554 urologic outpatients. Eur Urol. 2000;37:400-3.
26. Screponi E, Carosa E, Di Stasi SM, Pepe M, Carruba G, Jannini EA. Prevalence of chronic prostatitis in men with premature ejaculation. Urology. 2001;58:198-202.
27. Cruz N, Sáenz J, Navío S. Perspectiva histórica de la clasificación y diagnóstico clínico de las prostatitis. Urol Integr Invest. 2004;9:105-12.
28. Meares EM, Stamey TA. Bacteriological localization patterns in bacterial prostatitis and urethritis. Invest Urol. 1968;5:492-518.
29. Naber KG, Busch W, Focht J. Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. The German Prostatitis Study Group. Int J Antimicrob Agents. 2000;14:143-9.
30. Kiyota H, Onodera S, Ohishi Y, Tsukamoto T, Matsumoto T. Questionnaire survey of Japanese urologists concerning the diagnosis and treatment of chronic prostatitis and chronic pelvic pain syndrome. Int J Urol. 2003;10:636-42.
31. Nickel JC. The pre and postmasage test (PPMT): a simple screen for prostatitis. Tech Urol. 1997;3:38-43.
32. Mobley DF. Semen cultures in the diagnosis of bacterial prostatitis. J Urol. 1975;114:83-5.
33. Jiménez Cruz JF, Moreno B, Mascarós E, Acosta B, Gobernado M. Prostatitis crónica. Diagnóstico microbiológico. Act Urol Esp. 1988; Monográfico Infecciones Urinarias: 58-62.
34. Palmero JL, Budía A, Benedicto A, Queipo JA, Broseta E, Jiménez Cruz JF. Stamey-Meares tests in chronic prostatitis diagnosis. Is still a valid procedure? Europ Urol. 2003;Suppl 2:15, abstract 52.
35. Domingue GJ, Hellstrom WJG. Prostatitis. Clinic Microb Reviews. 1998;11:604-13.
36. Shahed AR, Shoskes DA.Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome: correlation with gram positive bacterial growth and treatment response. J Androl. 2000;21:669-75.
37. Ohkawa M, Yamaguchi K, Tokunaga S, Nakashima T, Fujita S. Ureaplasma urealyticum in the urogenital tract of patients with chronic prostatitis or related symptomatology. Br J Urol. 1993;72:918-21.
38. Badalyan RR, Fanarjyan SV, Aghajanyan IG. Chlamydial and ureaplasmal infections in patients with nonbacterial chronic prostatitis. Andrologia. 2003;35:263-5.
39. Krieger JN, Jacobs RR, Ross SO. Does the chronic prostatitis/pelvic pain syndrome differ from nonbacterial prostatitis and prostatodynia? J Urol. 2000;165:1554-8.
40. Schaeffer AJ. Epidemiology and demographics of prostatitis. Andrologia. 2003;35:252-7.
41. Nickel JC, Alexander RB, Schaeffer AJ, Landis JR, Knauss JS, Propert KJ. Chronic Prostatitis Collaborative Research Network Study Group. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol. 2003;170:818-22.
42. Lorence D, Villanueva S. Citología inflamatoria en la prostatitis crónica (CP/CPPS). Urol Integr Invest. 2004;9:127-32.
43. Rodríguez Patrón R, Mayayo T, Sanz E. Técnicas de imagen en patología inflamatoria prostática. Urol Integr Invest. 2004;9:133-9.
44. Pansadoro V, Emiliozzi P, Defidio L, Scarpone P, Sabatini G, Brisciani A, et al. Prostate-specific antigen and prostatitis in men under fifty. Eur Urol. 1996;30:24-27.
45. Kravchick S, Cytron S, Agulansky L, Ben-Dor D. Acute prostatitis in middle-aged men: a prospective study. BJU Int. 2004;93:93-6.
46. Alexander RB, Ponniah S, Hasday J, Hebel JR. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology. 1998;52:744-9.
47. True LD, Berger RE, Rothman I, Ross SO, Krieger JN. Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study. J Urol. 1999;162:2014-8.
48. Dimitrakov J, Diemer T, Ludwig M, Weidner W. Recent developments in diagnosis and therapy ofthe prostatitis syndromes. Curr Op Urol. 2001;11:87-91.
49. Jiménez Cruz JF, Broseta E. Bladder neck obstruction. En: Whitfield et al, editors. Textbook of genitourinary surgery. Oxford: Blackwell Science Ltd; 1998. p. 532-46.
50. Nickel JC. Classification and diagnosis of prostatitis: a gold standard? Andrologia. 2003;35:160-7.
51. Krieger JN. Prostatitis revisited: new definitions, new approaches. Infect Dis Clin North Am. 2003;17:395-409.
52. Elert A, Von Knobloch R, Nusser R, Heidenreich A, Hofmann R. Isolated candidal prostatitis. J Urol. 2000;163:244.
53. Shoskes DA. Use of antibiotics in chronic prostatic syndromes. Can J Urol. 2001;8:24-8.
54. Charalabopoulos K, Karachalios G, Baltogiannis D, Charalabopoulos A, Giannakopoulos X, Sofikitis N. Penetration of antimicrobial agents into the prostate. Chemotherapy. 2003;49:269-79.
55. Khastgir J, Dickinson AJ. Where do we stand with chronic prostatitis? An update. Hosp Med. 2003;64:732-6.
56. Baert L, Leonard A. Chronic bacterial prostatitis: 10 years of experience with local antibiotics. J Urol. 1988;140:755-7.
57. Jiménez Cruz JF, Boronat F, Gallego J. Treatment of chronic prostatitis: Intraprostatic antibiotic injections under echographic control. J Urol. 1988;139:967-70.
58. Nickel JC, Downey J, Johnston B, Clark J, Group TC, The Canadian Prostatitis Research Group. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol. 2001;165:1539-44.
59. Nickel JC, Downey J, Clark J, Casey RW, Pommerville PJ, Barkin J, et al. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology. 2003;62:614-7.
60. Olavi L, Make L, Imo M. Effects of finasteride in patients with chronic idiopathic prostatitis: a double-blind placebo-controlled pilot study. Eur Urol. 1998;33:24-9.
61. Barbalias GA, Nikiforidis G, Liatsikos EN. α-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol. 1998;159:883-7.
62. Nickel JC. Prostatitis: evolving management strategies. Urol Clin North Am. 1999;26:737-51.
63. Oschepkov V, Sivkov A, Dary E. Efficacy of transrectal microwave hyperthermia (TRMH) in the treatment of chronic prostatitis. A randomized sham controlled comparative study [abstract 115]. J Urol. 1999;161:333.
64. Liatsikos EN, Dinlec CZ, Kapoor R, Smith AD. Transurethral microwave thermotherapy for the treatment of prostatitis. J Endourol. 2000;14:689-92.
65. Kaplan SA, Volpe MA, Te AE. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol. 2004;171:284-8.
66. Evliyaoglu Y, Burgut R. Lower urinary tract symptoms, pain and quality of life assessment in chronic non-bacterial prostatitis patients treated with alpha-blocking agent doxazosin; versus placebo. Int Urol Nephrol. 2002;34:351-6.
67. Shoskes DA, Manickam K. Herbal and complementary medicine in chronic prostatitis. World J Urol. 2003;21:109-13.
68. Anderson RU, Wise D, Meadows M. Myofascial release therapy for category III chronic prostatitis. J Urol. 1999;161:34-9.
69. Merskey H. Pharmacological approaches other than opioids in chronic non-cancer pain management. Acta Anaesthesiol Scand. 1997;41:187-91.
70. Shoskes DA, Hakim L, Ghoniem G, Jackson CL. Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. J Urol. 2003;169:1406-10.
71. Merahn S. Prostatitis. En: PDxMD renal and genitourinary disorders. Philadelphia: Elsevier; 2003. p. 553-80.
72. Lacquanti S, Fulcoli V, Weir JM, Pisanti F, Servello C, Destito A. Bacterial prostatitis: urine and spermatic urine culture. Arch Ital Urol Androl. 2000;72:21-3.
73. Elert A, Von Knobloch R, Nusser R, Heidenreich A, Hofmann R. Isolated candidal prostatitis. J Urol. 2000;163:244.
74. Seo R, Oysau R, Schaeffer A. Blastomycosis of the epididymis and prostate. Urology. 1997;50:980-2.
75. Abbas S, Kamal MK, Talati J. Prostatic aspergillosis. J Urol. 1995;153:748-50.